196 related articles for article (PubMed ID: 8701415)
1. Effect of lipoprotein(a) and LDL on plasminogen binding to extracellular matrix and on matrix-dependent plasminogen activation by tissue plasminogen activator.
Pekelharing HL; Kleinveld HA; Duif PF; Bouma BN; van Rijn HJ
Thromb Haemost; 1996 Mar; 75(3):497-502. PubMed ID: 8701415
[TBL] [Abstract][Full Text] [Related]
2. Lysine-binding heterogeneity of Lp(a): consequences for fibrin binding and inhibition of plasminogen activation.
Bas Leerink C; Duif PF; Gimpel JA; Kortlandt W; Bouma BN; van Rijn HJ
Thromb Haemost; 1992 Aug; 68(2):185-8. PubMed ID: 1412165
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of Apo(a) kringle IV-10 and plasminogen kringles on the interactions of lipoprotein(a) with regulatory molecules.
Xue S; Green MA; LoGrasso PV; Boettcher BR; Madison EL; Curtiss LK; Miles LA
Thromb Haemost; 1999 Mar; 81(3):428-35. PubMed ID: 10102473
[TBL] [Abstract][Full Text] [Related]
4. Modification of lipoprotein(a) by oxidation or desialylation influences its ability to compete with plasminogen for binding to the extracellular matrix.
Pekelharing HL; Kleinveld HA; Duif PF; Bouma BN; van Rijn HJ
Blood Coagul Fibrinolysis; 1996 Sep; 7(6):641-9. PubMed ID: 8899154
[TBL] [Abstract][Full Text] [Related]
5. Binding of recombinant apolipoprotein(a) to human platelets and effect on platelet aggregation.
Martínez C; Rivera J; Loyau S; Corral J; González-Conejero R; Lozano ML; Vicente V; Anglés-Cano E
Thromb Haemost; 2001 Apr; 85(4):686-93. PubMed ID: 11341506
[TBL] [Abstract][Full Text] [Related]
6. Lipids and progression of renal disease: role of modified low density lipoprotein and lipoprotein(a).
Wanner C; Greiber S; Krämer-Guth A; Heinloth A; Galle J
Kidney Int Suppl; 1997 Dec; 63():S102-6. PubMed ID: 9407434
[TBL] [Abstract][Full Text] [Related]
7. Absence of inhibition by lipoprotein (a) inhibition of tPA induced thrombolysis in a patient's plasma milieu.
Lu H; Bruckert J; Soria J; Li H; de Gennes JL; Legrand A; Peynet J; Soria C
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):513-6. PubMed ID: 1966796
[TBL] [Abstract][Full Text] [Related]
8. Interaction of Lp(a) with plasminogen binding sites on cells.
Miles LA; Fless GM; Scanu AM; Baynham P; Sebald MT; Skocir P; Curtiss LK; Levin EG; Hoover-Plow JL; Plow EF
Thromb Haemost; 1995 Mar; 73(3):458-65. PubMed ID: 7667829
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein lipase greatly enhances the retention of lipoprotein(a) to endothelial cell-matrix.
Auerbach BJ; Cain W; Ansong M; Newton RS; Saxena U; Bisgaier CL
Atherosclerosis; 1999 Jan; 142(1):89-96. PubMed ID: 9920509
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein(a) binds to low-density lipoprotein at two distant sites in lipoprotein(a).
Xu S
Biochemistry; 1998 Jun; 37(26):9284-94. PubMed ID: 9649309
[TBL] [Abstract][Full Text] [Related]
11. A potential basis for the thrombotic risks associated with lipoprotein(a).
Miles LA; Fless GM; Levin EG; Scanu AM; Plow EF
Nature; 1989 May; 339(6222):301-3. PubMed ID: 2542796
[TBL] [Abstract][Full Text] [Related]
12. Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100.
Gabel BR; Koschinsky ML
Biochemistry; 1998 May; 37(21):7892-8. PubMed ID: 9601051
[TBL] [Abstract][Full Text] [Related]
13. Definition of the structural elements in plasminogen required for high-affinity binding to apolipoprotein(a): a study utilizing surface plasmon resonance.
Hancock MA; Spencer CA; Koschinsky ML
Biochemistry; 2004 Sep; 43(38):12237-48. PubMed ID: 15379562
[TBL] [Abstract][Full Text] [Related]
14. Acetyl-LDL stimulates macrophage-dependent plasminogen activation and degradation of extracellular matrix.
Falcone DJ; Ferenc MJ
J Cell Physiol; 1988 Jun; 135(3):387-96. PubMed ID: 3397384
[TBL] [Abstract][Full Text] [Related]
15. Oxidative modifications of LDL increase its binding to extracellular matrix from human aortic intima: influence of lesion development, lipoprotein lipase and calcium.
Wang X; Greilberger J; Ratschek M; Jürgens G
J Pathol; 2001 Sep; 195(2):244-50. PubMed ID: 11592105
[TBL] [Abstract][Full Text] [Related]
16. Oxidized LDL binding to a macrophage-secreted extracellular matrix.
Kaplan M; Aviram M
Biochem Biophys Res Commun; 1997 Aug; 237(2):271-6. PubMed ID: 9268699
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein(a): a genetically determined lipoprotein containing a glycoprotein of the plasminogen family.
Scanu AM
Semin Thromb Hemost; 1988 Jul; 14(3):266-70. PubMed ID: 2972066
[TBL] [Abstract][Full Text] [Related]
18. Oxidation decreases low density lipoprotein association with the subendothelium extracellular matrix.
Savion N; Zavaro O; Kotev-Emeth S
Biochem Biophys Res Commun; 1998 Apr; 245(2):497-501. PubMed ID: 9571183
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of fibrinolysis by lipoprotein(a).
Anglés-Cano E; de la Peña Díaz A; Loyau S
Ann N Y Acad Sci; 2001; 936():261-75. PubMed ID: 11460483
[TBL] [Abstract][Full Text] [Related]
20. Tissue-type plasminogen activator binds to and is inhibited by surface-bound lipoprotein(a) and low-density lipoprotein.
Simon DI; Fless GM; Scanu AM; Loscalzo J
Biochemistry; 1991 Jul; 30(27):6671-7. PubMed ID: 1829635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
